CN113061120B - Styryl oxadiazole compound and preparation method and application thereof - Google Patents

Styryl oxadiazole compound and preparation method and application thereof Download PDF

Info

Publication number
CN113061120B
CN113061120B CN202110255825.8A CN202110255825A CN113061120B CN 113061120 B CN113061120 B CN 113061120B CN 202110255825 A CN202110255825 A CN 202110255825A CN 113061120 B CN113061120 B CN 113061120B
Authority
CN
China
Prior art keywords
styryl
preparation
oxadiazole
oxadiazole compound
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202110255825.8A
Other languages
Chinese (zh)
Other versions
CN113061120A (en
Inventor
陈平
李康明
胡艾希
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changsha University of Science and Technology
Original Assignee
Changsha University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changsha University of Science and Technology filed Critical Changsha University of Science and Technology
Priority to CN202110255825.8A priority Critical patent/CN113061120B/en
Publication of CN113061120A publication Critical patent/CN113061120A/en
Application granted granted Critical
Publication of CN113061120B publication Critical patent/CN113061120B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The invention relates to styryl oxadiazole compounds shown as a structural formula I, a preparation method thereof and application of the styryl oxadiazole compounds as bactericides.
Figure DDA0002967013190000011
Wherein R is1~R2Selected from: C1-C2 alkyl, C3-C4 straight-chain alkyl or C3-C5 allyl; r is selected from: hydrogen, 4-bromo, 2, 4-dichloro.

Description

Styryl oxadiazole compound and preparation method and application thereof
Technical Field
The invention relates to a preparation method and application of a new compound, in particular to a styryl oxadiazole compound and application thereof in preparing a bactericide.
Background
The pesticide is famone, herbicide oxadiazon, oxadiargyl and the like.
Figure BDA0002967013180000011
Ihaojiao et al [ CN104592216B, 2017.2.15 grant ] describe the preparation of 5-phenyl-1, 3, 4-oxadiazole derivatives (A). The 5-phenyl-1, 3, 4-oxadiazole derivative is used as a bactericide for killing rhizoctonia solani, sclerotinia sclerotiorum, botrytis cinerea, erysiphe graminis and phytophthora capsici.
Figure BDA0002967013180000012
In 2006, Li et al [ Bioorganic & Medicinal Chemistry Letters,2006,16(8): 2278-.
Figure BDA0002967013180000013
R=H,4-OCH3,4-OCH2C6H5,3-Cl,2,3-Cl2,2,4-Cl2,2,5-Cl2,2,4-Cl2-5-F,2-F,4-F,2-F-4-Br,2,3-F2,4-CF3,2-I,4-NO2
Wherein compound B (R ═ 4-F, 2-F-4-Br, 2,3-F250mg/L) of the inhibitor, the inhibition rates of the verticillium dahliae and the botrytis cinerea are both 100 percent.
The invention aims to develop a styryl oxadiazole compound bactericide with a novel structure.
Disclosure of Invention
The invention aims to provide styryl oxadiazole compounds, a preparation method thereof and application of the styryl oxadiazole compounds as bactericides.
In order to solve the technical problem, the invention provides the following technical scheme:
the first aspect of the technical scheme of the invention provides a styryl oxadiazole compound shown as a structural formula I:
Figure BDA0002967013180000021
wherein R is1~R2Selected from: C1-C2 alkyl, C3-C4 straight-chain alkyl or C3-C5 allyl; r is selected from: hydrogen, 4-bromo, 2, 4-dichloro.
In a second aspect of the technical scheme of the present invention, a preparation method of styryl oxadiazole compounds is provided, wherein the preparation reaction of the compound represented by formula I is as follows:
Figure BDA0002967013180000022
wherein R is1~R2Selected from the group consisting of: C1-C2 alkyl, C3-C4 straight-chain alkyl or C3-C5 allyl; r is selected from: hydrogen, 4-bromo, 2, 4-dichloro; x is selected from: chlorine, bromine or iodine.
The third aspect of the technical scheme of the invention is to provide an application of the styryl oxadiazole compound in the preparation of bactericides.
The beneficial technical effects are as follows:
the styryl oxadiazole compound is a compound with bactericidal activity or insecticidal activity.
Figure BDA0002967013180000023
Detailed Description
The following examples are intended to illustrate the invention without further limiting it.
Example 1
(E) Preparation of methyl (E) -2- (methoxyimino) -2- (2- (((5- ((E) -styryl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) acetate (I1)
Figure BDA0002967013180000024
1.0mmol of (E) -5-styryl-2-mercapto-1, 3, 4-oxadiazole, 1.1mmol of potassium carbonate, 5mL of acetonitrile and 0.6mmol of potassium iodide, adding 1.05mmol of (E) -2-bromomethyl-alpha-methoxyimino phenylacetic acid methyl ester in batches under stirring at room temperature, heating to reflux, reacting for 3h, desolventizing under reduced pressure, extracting with ethyl acetate, washing with water, drying with anhydrous sodium sulfate, desolventizing, and separating by column chromatography (V)Petroleum ether∶VEthyl acetate10: 1) to give methyl (E) -2- (methoxyimino) -2- (2- (((5- ((E) -styryl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) acetate (I1) in 83.8% yield; white solid with a melting point of 140-142 ℃;1H NMR(400MHz,CDCl3)δ:7.55~6.94(m,9H,Ar-H),7.62(d,J=6.8Hz,1H,CH=CH),7.18(d,J=6.8Hz,1H,CH=CH),4.39(s,2H,SCH2),4.09(s,3H,NOCH3),3.90(s,3H,OCH3);13C NMR(101MHz,CDCl3)δ:165.46,163.50,163.24,149.05,138.70,134.72,133.99,130.57,130.22,129.94,129.86,129.00,128.66,128.09,127.46,109.58,63.93,53.16,34.72。
example 2
(E) Preparation of methyl (E) -2- (2- (((5- ((E) -4-bromophenylvinyl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) -2- (methoxyimino)) acetate (I19)
Figure BDA0002967013180000031
Prepared according to the method of example 1, 1.0mmol of (E) -5- (4-bromostyreneReaction of yl) -2-mercapto-1, 3, 4-oxadiazole and 1.05mmol of (E) -2-bromomethyl- α -methoxyiminophenylacetic acid methyl ester for 3h to give (E) -methyl 2- (2- (((5- ((E) -4-bromostyryl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) -2- (methoxyimino)) acetate (I19) in 78.9% yield;1H NMR(400MHz,CDCl3)δ:7.65~7.35(m,8H,2×C6H4),7.18(d,J=16.4Hz,1H,CH=CH),6.97(d,J=16.4Hz,1H,CH=CH),4.39(s,2H,CH2),4.08(s,3H,NOCH3),3.90(s,3H,OCH3)。
example 3
(E) Preparation of methyl (l) -2- (2- (((5- ((E) -2, 4-dichlorostyryl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) -2- (methoxyimino)) acetate (I3)
Figure BDA0002967013180000032
Prepared according to the method of example 1, 1.0mmol of (E) -5- (2, 4-dichlorostyryl) -2-mercapto-1, 3, 4-oxadiazole and 1.05mmol of (E) -2-bromomethyl- α -methoxyiminophenylacetic acid methyl ester were reacted for 3h to give (E) -methyl 2- (2- (((5- ((E) -2, 4-dichlorostyryl) -1,3, 4-oxadiazol-2-yl) mercapto) methyl) phenyl) -2- (methoxyimino)) acetate (I3) in 74.5% yield; yellow solid with melting point of 129-131 ℃;1H NMR(400MHz,CDCl3)δ:7.74(d,J=16.4Hz,1H,CH=CH),7.65~7.15(m,4H,C6H4),7.44(m,3H,C6H3),6.97(d,J=16.4Hz,1H,CH=CH),4.40(s,2H,SCH2),4.09(s,3H,NOCH3),3.90(s,3H,OCH3);13C NMR(101MHz,CDCl3)δ:164.97,164.15,163.24,149.06,136.03,134.99,133.91,133.16,131.52,130.59,130.24,130.03,129.87,128.70,128.15,127.73,112.44,63.95,53.19,34.74。
example 4
Determination of bactericidal activity of styryl oxadiazole compound
Purpose of the test
The toxicity of the new compound to various pathogenic bacteria under the test concentration is measured indoors, and the bactericidal activity of the new compound is preliminarily evaluated.
2 conditions of the test
2.1 test target
Cucumber Botrytis cinerea (Botrytis cinerea), Alternaria tabaci (Alternaria alternata), wheat gibberellic disease (Gibberella zeae), Sclerotinia sclerotiorum (Sclerotinia sclerotiorum) and Phytophthora capsici (Phytophthora capsicii), all of which are stored in a refrigerator (4-8 ℃), inoculated into a culture dish from a test tube slant for 2-3 days before the test, and cultured at a proper temperature for the test. The culture medium for experiments is potato agar medium (PDA).
2.2 culture conditions
The culture conditions of the test target and the tested target are that the temperature is 25 +/-5 ℃ and the relative humidity is 65 +/-5 percent
2.3 instrumentation
A beaker, a pipette, a measuring cylinder, a culture dish, an autoclave, a constant temperature biochemical incubator and the like.
Design of the experiment
3.1 test agents: the compounds of the examples.
3.2 test concentrations
The concentration of the in vitro medicament is set to be 25 mg/L; the concentration of the corn rust disease germ and wheat powdery mildew disease medicament is set to be 500 mg/L.
3.3 preparation of the medicament
Raw materials: weighing the required amount by using a ten-thousandth electronic balance; solvent: n, N-Dimethylformamide (DMF), 0.2%; emulsifier: tween80, 0.1%;
and (3) ordinary sieve determination: accurately weighing 0.0500g of sample, dissolving with 0.20mL of DMMF, adding 98.8mL of sterile water containing 0.1% of Tween80 emulsifier, stirring uniformly, and preparing into 500mg/L concentration solution for later use.
4 test method
Refer to "evaluation of biological Activity of pesticides SOP".
Botrytis cinerea, alternaria alternata, fusarium graminearum, sclerotinia sclerotiorum and phytophthora capsici: according to the raw measurement standard method NY/T1156.2-2006, a drug-containing culture medium method is adopted: 2mL of each 500mg/L compound solution was added to 38mL of PDA cooled to 45 ℃ to prepare a drug-containing medium plate with a final concentration of 25 mg/L. Then, 6.5mm diameter hypha blocks are taken from the edge of the cultured test germ colony and transferred to a culture medium containing the medicine, and the treatment is repeated for 4 times. After the treatment, the cells were cultured in a constant temperature biochemical incubator at 28 ℃ for 4 days, and the diameter of the colonies was measured to calculate the growth inhibition rate.
5 evaluation of Fungicide Activity
After treatment, the morbidity and the hypha growth of the leaves and the plants are regularly observed and recorded, and the control effect and the inhibition rate are calculated according to the disease index and the hypha diameter.
Figure BDA0002967013180000041
The in vitro bactericidal activity (25. mu.g/mL) and in vivo bactericidal activity (500mg/L) of styryl oxadiazole compounds are shown in Table 1 below:
TABLE 1 fungicidal Activity of Compounds I1-I3 (25. mu.g/mL)
Figure BDA0002967013180000051
The bactericidal activity (control effect) of the compound I3(500mg/L) on the living bodies of erysiphe graminis and corn rust is 50% and 95% respectively.
The activity results show that: the styryl oxadiazole compound has good bactericidal activity and can be used for preparing bactericides and applied to agriculture.

Claims (3)

1. A styryl oxadiazole compound shown as a structural formula I:
Figure FDA0003622783030000011
wherein R is1~R2Selected from: C1-C2 alkyl or C3-C4 straightA chain alkyl group; r is selected from: hydrogen, 4-bromo, 2, 4-dichloro.
2. The process for producing a styryl oxadiazole compound according to claim 1, characterized by the following reaction:
Figure FDA0003622783030000012
wherein, R, R1And R2Is as defined in claim 1; x is selected from: chlorine, bromine or iodine.
3. Use of the styryl oxadiazole compound of claim 1 for preparing a bactericide against Alternaria alternata, Fusarium graminearum, Botrytis cinerea, Blumeria graminis, or Puccinia zeae.
CN202110255825.8A 2021-03-09 2021-03-09 Styryl oxadiazole compound and preparation method and application thereof Expired - Fee Related CN113061120B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110255825.8A CN113061120B (en) 2021-03-09 2021-03-09 Styryl oxadiazole compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110255825.8A CN113061120B (en) 2021-03-09 2021-03-09 Styryl oxadiazole compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN113061120A CN113061120A (en) 2021-07-02
CN113061120B true CN113061120B (en) 2022-07-12

Family

ID=76560385

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110255825.8A Expired - Fee Related CN113061120B (en) 2021-03-09 2021-03-09 Styryl oxadiazole compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113061120B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0007822A (en) * 1999-01-15 2002-02-19 Bayer Ag Derivatives of n-alkoxy-phenylcarbamates
MXPA03002442A (en) * 2000-09-19 2004-05-05 Dow Agrosciences Llc Thiazole derivatives of 2-methoxyimino-2-(pyridinyloxymethyl)-phenyl-acetamides useful as fungicides.
CN102603669B (en) * 2012-04-05 2014-10-22 南开大学 Derivatives of alpha-methoxyl imino-5-methyl-1,2,3-thiadiazole-4- carboxylic acid methyl ester and preparation methods and uses thereof
CN103980223B (en) * 2014-05-23 2016-11-09 贵州大学 2-substituent group-5-substituted anilinic-1,3,4-diazoles derivant and synthetic method thereof and application
CN109535144A (en) * 2019-01-08 2019-03-29 贵州大学 A kind of 1,3,4- oxadiazoles thio-ether type compounds and its preparation method and application
CN109651350B (en) * 2019-01-11 2022-05-24 贵州大学 Heterocyclic substituted 1,3,4-oxa (thia) diazoles compound and preparation method and application thereof
CN110367265B (en) * 2019-08-26 2022-02-15 浙江工业大学 Application of stilbene analogue containing phenylthiazole structure as bactericide

Also Published As

Publication number Publication date
CN113061120A (en) 2021-07-02

Similar Documents

Publication Publication Date Title
US5004816A (en) Aminopyrrole intermediates for fungicides
JPS6147403A (en) Method of repelling plant pathoginic fungi by use of fungicidal composition containing n-acetonylbenzamide
FI94412B (en) Acrylate fungicide and their use
CN107652250B (en) Thiazole amide compounds, and preparation method and application thereof
Sanemitsu et al. Synthesis and herbicidal activity of 2-acylimino-3-phenyl-1, 3-thiazolines—A new family of bleaching herbicides—
CN103664808A (en) Aryl triazole compound containing chlorinated cyclopropane and preparation method and application thereof
CN104592216A (en) 5-phenyl-1,3,4-oxadiazole derivative as well preparation method and application thereof
CN108864007B (en) 2-aminomethyl-6- (benzofuran-5-yl) phenol and preparation method and application thereof
CN113061120B (en) Styryl oxadiazole compound and preparation method and application thereof
CN110066286B (en) Phenylpyrazoline compound with biological activity and preparation method and application thereof
CN107089975B (en) The thiazole salt compounds and preparation method and application of the base of oxadiazoles containing 1,3,4-
CN114644574B (en) Dioxime ether compound and preparation method and application thereof
CN104370891B (en) A kind of 5-(butylene lactone-3-ethylidene)-2-aminooimidazole quinoline ketone compounds, preparation method and applications
KR950007593B1 (en) Process for preparing isoxazolylethand derivatives
CN112898222B (en) Oxadiazole compound and preparation method and application thereof
JPH0762006B2 (en) 2-Substituted phenyl-2-oxa- or thiazoline derivatives, process for their production and insecticides and acaricides containing the same
JP3214906B2 (en) α-arylacrylic acid derivative and fungicide containing the compound
CN112661732B (en) Furanol derivative and preparation method and application thereof
KR100967889B1 (en) Antibacterial composition containing 2-iminobenzoimidazole derivatives
JPH04234874A (en) Substituted 2-(6-(pyrimidinyl)-indol-yl) acrylic ester and process for producing same
CN113563281A (en) Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof
CN102002018B (en) (2-oxo-benzothiazole)-3-diacetyl hydrazone compound as well as preparation method and application thereof
CN105924435B (en) A kind of substituted pyrazoles acetamides and its preparation method and application
CN115215761A (en) Diphenoxitol derivatives and their use as fungicides and insecticides
CN114957123B (en) 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20220712